As of 28 Aug 2026, Avience Biomedicals Ltd share price is ₹270.65. The stock opened at ₹270.65 and had closed at ₹275.10 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹222.00 and a high of ₹414.95. In terms of performance, Avience Biomedicals Ltd share price has increased by 4.24% over the past six months and has decreased by 34.78% over the last year.
AVIENCE Charts
Avience Biomedicals Ltd Overview
About AVIENCE
Avience Biomedicals is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
Avience Biomedicals Ltd Historical Performance
Avience Biomedicals Ltd Fundamental Analysis
Avience Biomedicals Ltd Financials
| Indicator | No Data Available |
|---|---|
| Revenue | |
| EBITDA | |
| Net Profit | |
| EPS |
Avience Biomedicals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 51.88 |
| MACD | -5.15 |
| 20-Day SMA | 251.85 |
Avience Biomedicals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Avience Biomedicals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,800.00+0.38% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,009.00+0.40% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹915.65+0.20% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Avience Biomedicals Ltd today is ₹270.65 on NSE and ₹270.65 on BSE.
- The 52-week high of Avience Biomedicals Ltd is ₹414.95, while the 52-week low is ₹222.00.
- The current market capitalisation of Avience Biomedicals Ltd is approximately ₹148 crore.
- The P/E (Price-to-Earnings) ratio of Avience Biomedicals Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Avience Biomedicals Ltd is 0.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Avience Biomedicals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Avience Biomedicals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Avience Biomedicals Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Avience Biomedicals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 64.59% promoters, 2.81% FIIs, 9.08% DIIs, and 13.57% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
